Cytochrome P450 enzyme polymorphisms and treatment-related ovarian toxicity in patients with SLE


BACKGROUND Treatment with pulse intravenous cyclo­ phosphamide is considered a standard therapy for patients with systemic lupus erythema­ tosus (SLE). Potential risks associated with treatment include an increased risk of ovarian toxicity, infection, and hemorrhagic cystitis. Ovarian toxicity is a major concern in young female patients receiving treatment… (More)
DOI: 10.1038/ncprheum0574


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics